Franklin Biolabs is a Philadelphia life-sciences company whose team has helped shape genetic medicine for more than four decades, with expertise carried forward from the University of Pennsylvania’s Penn Vector Core. Today, it serves biotechnology, pharmaceutical, and academic researchers as a preclinical CRO, helping advance therapies from early research toward clinical development.
Clinical Laboratory Improvement Amendments (CLIA)
AAALAC International
Compliance program
Office of Laboratory Animal Welfare (OLAW)
Compliance program
USDA
Registration
IACUC Animal Care and Use Committee
Compliance program
Good Clinical Laboratory Practice (GCLP)
Compliance program
Good Laboratory Practice (GLP)
Compliance program
Good Manufacturing Practice (GMP)
Compliance program
GLP
Quality certification
GMP
Quality certification
EMINENT Life SciencesWith more than 30 years of experience, EMINENT Life Sciences is a Frederick, Maryland company known for supporting clinical research organizations and public-health institutions. It brings together clinical laboratory and investigational drug management expertise to help researchers move studies forward across the United States, the European Union, and Australia.FREDERICK, MD
Andelyn BiosciencesBorn from decades of gene-therapy research at Nationwide Children’s Hospital, Columbus-based Andelyn Biosciences is a contract development and manufacturing organization that develops and produces viral vectors and plasmids for cell and gene therapies. Spun out as an independent company in January 2020, Andelyn carries a patient-centered origin story into work spanning early development through clinical and commercial manufacturing. Its two Ohio facilities support a record that includes more than 500 cGMP clinical batches and the production experience behind an FDA-approved systemic gene therapy.COLUMBUS, OH
AUM LifeTech, IncPhiladelphia-based AUM LifeTech develops RNA-targeting therapeutics through its proprietary AUM silence antisense oligonucleotide platform, which is designed to silence or regulate disease-linked RNA without an external delivery vehicle. Founded by biotechnology entrepreneur Veenu Aishwarya, the company is pursuing preclinical treatments for genetically defined diseases, including an anti-FOXP3 cancer-immunotherapy program developed with Children’s Hospital of Philadelphia. Its work also includes a Parkinson’s disease program conducted with the University of Pennsylvania.PHILADELPHIA, PA
J&W PharmlabFounded in 2002, Pennsylvania-based J&W Pharmlab is a contract research organization that performs custom organic synthesis and medicinal-chemistry research for life-science clients. Its 10,000-square-foot laboratory combines PhD-led project work with proprietary chiral-resolution methods and a portfolio of more than 30,000 novel building blocks. All custom synthesis is conducted domestically, with clients communicating directly with the scientist assigned to their project.LEVITTOWN, PA